Diaceutics PLC (DXRX.L)
GBp 124.0
(0.0%)
GBp 124.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.94 Million | 5.14 Million | 570 Thousand | 253 Thousand | -627.05 Thousand | -954.03 Thousand |
| Net Income | -1.74 Million | 724 Thousand | 561 Thousand | 263 Thousand | 397.88 Thousand | 632.3 Thousand |
| Depreciation & Amortization | 4.77 Million | 3 Million | 1.79 Million | 809 Thousand | 284.85 Thousand | 117.68 Thousand |
| Deferred income taxes | - | -6.96 Million | -5.68 Million | -1.42 Million | -2.09 Million | 2.15 Million |
| Stock-based compensation | 445 Thousand | 536 Thousand | 373 Thousand | 290 Thousand | 24 Thousand | 405.92 Thousand |
| Change in working capital | -1.54 Million | -328 Thousand | -1.65 Million | 486 Thousand | -1.5 Million | -2.52 Million |
| Other non-cash items | 11.54 Million | 8.08 Million | 5.12 Million | -173 Thousand | 2.26 Million | 3.57 Million |
| Investing Cash Flow | -4.85 Million | -4.87 Million | -5.6 Million | -6.29 Million | -2.92 Million | -1.1 Million |
| Investments in PPE | -4.85 Million | -4.87 Million | -5.6 Million | -6.29 Million | -2.92 Million | -1.1 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -4.08 Million | -4.57 Million | -5.03 Million | -6.15 Million | -2.82 Million | -1.04 Million |
| Financing Cash Flow | -228 Thousand | -132 Thousand | -270 Thousand | 19.61 Million | 13.29 Million | 1.04 Million |
| Debt repayment | -179 Thousand | -163 Thousand | -56 Thousand | - | -2.74 Million | -1.34 Million |
| Dividends payments | - | - | - | - | - | -300.21 Thousand |
| Common Stock Repurchased | -49 Thousand | -98 Thousand | -165 Thousand | - | - | 554.42 Thousand |
| Common Stock Issuance | - | 129 Thousand | - | 19.61 Million | 16.03 Million | 10.00 |
| Other Financing Activities | -11 Thousand | 191 Thousand | -49 Thousand | 19.61 Million | -4.00 | -301.56 Thousand |
| Accounts receivables | -2.15 Million | -1.59 Million | -1.49 Million | 549 Thousand | -2.32 Million | -2.55 Million |
| Accounts payables | 618 Thousand | 1.26 Million | -159 Thousand | -63 Thousand | 825.23 Thousand | 35.74 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 618 Thousand | - | - | - | - | -35.74 Thousand |
| Cash at beginning of period | 19.84 Million | 19.67 Million | 25.25 Million | 11.72 Million | 2.07 Million | 3.06 Million |
| Cash at end of period | 16.66 Million | 19.84 Million | 19.67 Million | 25.25 Million | 11.72 Million | 2.07 Million |
| Capital Expenditure | -4.85 Million | -4.87 Million | -5.6 Million | -6.29 Million | -2.92 Million | -1.1 Million |
| Effect of forex changes on cash | -37 Thousand | 20 Thousand | -279 Thousand | -38 Thousand | -93 Thousand | 18.46 Thousand |
| Net cash flow / Change in cash | -3.17 Million | 166 Thousand | -5.58 Million | 13.53 Million | 9.64 Million | -995.22 Thousand |
| Free Cash Flow | -2.9 Million | 278 Thousand | -5.03 Million | -6.04 Million | -3.55 Million | -2.06 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.58 Million | -261 Thousand | -1.74 Million | -1.48 Million | 724 Thousand | 1.49 Million |
| Depreciation & Amortization | 2.27 Million | 2.14 Million | 4.77 Million | 1.93 Million | 3 Million | 1.67 Million |
| Deferred income taxes | - | - | - | -4.26 Million | -6.96 Million | -5.1 Million |
| Stock-based compensation | - | 357 Thousand | 445 Thousand | 181 Thousand | 536 Thousand | 364 Thousand |
| Change in working capital | 2.84 Million | -2.2 Million | -1.54 Million | -220 Thousand | -328 Thousand | -1.39 Million |
| Other non-cash items | -1.03 Million | 573 Thousand | 11.54 Million | 4.8 Million | 8.08 Million | 4.86 Million |
| Investing Cash Flow | -1.44 Million | -1.51 Million | -4.85 Million | -2.94 Million | -4.87 Million | -2.49 Million |
| Investments in PPE | -61 Thousand | -64 Thousand | -4.85 Million | -2.94 Million | -4.87 Million | -2.49 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -1.45 Million | -4.08 Million | -2.63 Million | -4.57 Million | -2.24 Million |
| Financing Cash Flow | 37 Thousand | -98 Thousand | -228 Thousand | -141 Thousand | -132 Thousand | -87 Thousand |
| Debt repayment | - | -13 Thousand | -179 Thousand | -13 Thousand | -163 Thousand | -35 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -19 Thousand | -49 Thousand | -30 Thousand | -98 Thousand | -8000.00 |
| Common Stock Issuance | 135 Thousand | - | - | - | 129 Thousand | - |
| Other Financing Activities | -98 Thousand | -79 Thousand | -11 Thousand | -13 Thousand | 191 Thousand | -138 Thousand |
| Accounts receivables | 1.61 Million | -2.2 Million | -2.15 Million | 45 Thousand | -1.59 Million | -2.37 Million |
| Accounts payables | 1.22 Million | 883 Thousand | 618 Thousand | -265 Thousand | 1.26 Million | 973 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 16.66 Million | 17.88 Million | 19.84 Million | 19.84 Million | 19.67 Million | 20.38 Million |
| Cash at end of period | 16.74 Million | 16.66 Million | 16.66 Million | 17.88 Million | 19.84 Million | 19.84 Million |
| Capital Expenditure | -61 Thousand | -64 Thousand | -4.85 Million | -2.94 Million | -4.87 Million | -2.49 Million |
| Effect of forex changes on cash | - | -212 Thousand | -37 Thousand | 175 Thousand | 20 Thousand | 146 Thousand |
| Net cash flow / Change in cash | 81.99 Thousand | -1.21 Million | -3.17 Million | -1.96 Million | 166 Thousand | -547 Thousand |
| Free Cash Flow | 1.44 Million | 549 Thousand | -2.9 Million | -1.99 Million | 278 Thousand | -606 Thousand |
CJEWF
4270
TCCPY
JBL
002846
MDLN